Pharmaceutical Business Review
Return to: PBR Home | Companies

Abeona Therapeutics Inc

Abeona Therapeutics Inc
Suite 600
3333 Lee Parkway
United States of America
Phone: 1 214 6659495

No. employees: 19
Turnover: 01.04 (US$m)
Financial year end: December

Company Overview

Top Competitors

Key Employees

Jeffrey B. Davis

Director, Chief Operating Officer, Executive Board

Steven H. Rouhandeh

Chairman, Executive Board

Timothy J. Miller, Ph.D.

Director, Chief Executive Officer, President, Executive Board

Stephen B. Howell

Director, Non Executive Board

Mark J. Alvino

Director, Non Executive Board

Todd Wider

Director, Non Executive Board

Harrison G. Wehner

Executive Vice President, Senior Management

David P. Nowotnik, Ph.D.

Senior Vice President - Research and Development, Senior Management

Kaye Spratt, Ph.D.

Vice President - Regulatory and Quality Assurance, Senior Management

Michelle Berg

Vice President - Patient Advocacy, Senior Management

Adam Davis

Director - Manufacturing, Senior Management

Christine Berni-Silverstein

Vice President - Investor Relations, Senior Management

Juan Ruiz, Ph.D.,

Chief Medical Officer, Senior Management


Suite 600,
3333 Lee Parkway,
United States of America
Phone: 1 214 6659495

MacroChem Corp

40 Washington Street,
Suite 220,
Wellesley Hills,
United States of America
Phone: 1 781 4897310

Virium Pharmaceuticals Inc

116 Village Boulevard,
Suite 200,
New Jersey,
United States of America
Phone: 1 609 9512270
Fax: 1 609 5201702



  • MuGard
  • Technologies:
  • Mucoadhesive Hydrogel Technology
  • Pipeline Products
  • ABO-101 for MPS III B
  • ABO-102 for MPS III A
  • EB-101 for Recessive Dystrophic Epidermolysis Bullosa
  • EB-201 for Epidermolysis Bullosa
  • ABO-201 (AAV-CLN3) for Juvenile Batten disease
  • ABO-202 (AAV-CLN1) for Infantile Batten disease
  • ABO-301 (AAV-FANCC) for Fanconi Anemia Disorder
  • ABO-302 for Rare Blood Diseases